Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
4 astronauts are now on their path to the moon. Here’s what happens next- An Artemis 2 astronaut took a 'bath' on camera on the way to the moon. Mission Control's reaction was priceless (video)
- West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- Brexit's Effect on New York's Ascent as a Main Monetary Center
- NASA's Apollo 8 moonshot saved 1968. Could Artemis 2 do the same in 2026?
- Does physics say that free will doesn't exist?
- Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs
- New Gaza militia declares war on Hamas: 'Your dirty shoes are more honorable'
- Inside The Design-Forward Wellness Hotel Marking A New Chapter In Medellín
